EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

LinTT1-Functionalized Hybrid Lipid–Polymer Nanoparticles for Glioblastoma Targeting

Antonella Rocchi iD, Valeria Sidorenko, Nicola d'Avanzo, Luca Marchetti, Jhalak Sethi, Luigi Ciriolo, Anna Maria Tolomeo, Maria Grazia Cifone, Paola Palumbo, Massimo Fresta iD, Tambet Teesalu, Christian Celia iD

ACS Pharmacology & Translational Science · 10.10.2025 · 8 (10) · 3654-3668

DOI: 10.1021/acsptsci.5c00537 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Pharmacology & Translational Science, online erschienen am 30.09.2025. Verfasst von Antonella Rocchi und 11 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Precision and Nanomedicine, Institute of Biomedicine and Translational Medicine, University of Tartu, Ravila 14b, Tartu 50411, Estonia. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 92 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Transcan, Consiglio Nazionale delle Ricerche, Estonian Research Competency Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

CendR peptideglioblastoma multiformehybrid nanoparticlesnanomedicineprecision medicinetumor homing peptides

Autor:innen und Institutionen

  • Laboratory of Precision and Nanomedicine, Institute of Biomedicine and Translational Medicine, University of Tartu, Ravila 14b, Tartu 50411, Estonia.
  • Department of Pharmacy, University of Chieti - Pescara "G. d'Annunzio", Via dei Vestini 31, Chieti 66100, Italy.
  • Division of GI/Endocrine Surgery, Department of Surgery, Columbia University Irving Medical Center, New York, New York 10032, United States.
  • Department of Clinical and Experimental Medicine, University of Catanzaro "Magna Græcia", V.le "S. Venuta", Catanzaro I-88100, Italy.
  • Research Center "ProHealth Translational Hub", Department of Experimental and Clinical Medicine, "Magna Graecia" University of Catanzaro, Campus Universitario "S. Venuta" - Building of BioSciences, Viale S. Venuta, Cata…
  • Department of Health Science, University of Catanzaro "Magna Græcia", V.le "S. Venuta", Catanzaro I-88100, Italy.

ORCID-Profile: Antonella Rocchi, Massimo Fresta, Christian Celia

Förderung

  • Transcan
  • Consiglio Nazionale delle Ricerche
  • Estonian Research Competency Council
  • Ministero dell'Universit? e della Ricerca
  • EuroNanoMed III
  • NextGenerationEU

Zitieren

APA

Rocchi, A., Sidorenko, V., d'Avanzo, N., Marchetti, L., Sethi, J., Ciriolo, L., Tolomeo, A. M., Cifone, M. G., Palumbo, P., Fresta, M., Teesalu, T., & Celia, C. (2025). LinTT1-Functionalized Hybrid Lipid–Polymer Nanoparticles for Glioblastoma Targeting. ACS Pharmacology & Translational Science, 8(10), 3654-3668. https://doi.org/10.1021/acsptsci.5c00537

Vancouver

Rocchi A, Sidorenko V, d'Avanzo N, Marchetti L, Sethi J, Ciriolo L, et al. LinTT1-Functionalized Hybrid Lipid–Polymer Nanoparticles for Glioblastoma Targeting. ACS Pharmacology & Translational Science. 2025;8(10):3654-3668. doi:10.1021/acsptsci.5c00537

BibTeX
@article{Rocchi2025,
  author = {Rocchi, Antonella and Sidorenko, Valeria and d'Avanzo, Nicola and Marchetti, Luca and Sethi, Jhalak and Ciriolo, Luigi and Tolomeo, Anna Maria and Cifone, Maria Grazia and Palumbo, Paola and Fresta, Massimo and Teesalu, Tambet and Celia, Christian},
  title = {LinTT1-Functionalized Hybrid Lipid–Polymer Nanoparticles for Glioblastoma Targeting},
  journal = {ACS Pharmacology & Translational Science},
  year = {2025},
  volume = {8},
  number = {10},
  pages = {3654--3668},
  doi = {10.1021/acsptsci.5c00537}
}
Kostenlos starten →